Copyright Reports & Markets. All rights reserved.

Global Verapamil Hydrochloride Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Verapamil Hydrochloride Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Oral
    • 1.3.3 Intravenous Injection
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Verapamil Hydrochloride Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinics
    • 1.4.4 Other
  • 1.5 Global Verapamil Hydrochloride Injection Market Size & Forecast
    • 1.5.1 Global Verapamil Hydrochloride Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Verapamil Hydrochloride Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Verapamil Hydrochloride Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Verapamil Hydrochloride Injection Product and Services
    • 2.1.4 Pfizer Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Exela Pharma
    • 2.2.1 Exela Pharma Details
    • 2.2.2 Exela Pharma Major Business
    • 2.2.3 Exela Pharma Verapamil Hydrochloride Injection Product and Services
    • 2.2.4 Exela Pharma Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Exela Pharma Recent Developments/Updates
  • 2.3 Mankind Pharma
    • 2.3.1 Mankind Pharma Details
    • 2.3.2 Mankind Pharma Major Business
    • 2.3.3 Mankind Pharma Verapamil Hydrochloride Injection Product and Services
    • 2.3.4 Mankind Pharma Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Mankind Pharma Recent Developments/Updates
  • 2.4 ACIC Pharmaceuticals
    • 2.4.1 ACIC Pharmaceuticals Details
    • 2.4.2 ACIC Pharmaceuticals Major Business
    • 2.4.3 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Product and Services
    • 2.4.4 ACIC Pharmaceuticals Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ACIC Pharmaceuticals Recent Developments/Updates
  • 2.5 Zydus Pharmaceuticals
    • 2.5.1 Zydus Pharmaceuticals Details
    • 2.5.2 Zydus Pharmaceuticals Major Business
    • 2.5.3 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Product and Services
    • 2.5.4 Zydus Pharmaceuticals Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Zydus Pharmaceuticals Recent Developments/Updates
  • 2.6 Gland Pharma
    • 2.6.1 Gland Pharma Details
    • 2.6.2 Gland Pharma Major Business
    • 2.6.3 Gland Pharma Verapamil Hydrochloride Injection Product and Services
    • 2.6.4 Gland Pharma Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Gland Pharma Recent Developments/Updates
  • 2.7 China Res Double-Crane
    • 2.7.1 China Res Double-Crane Details
    • 2.7.2 China Res Double-Crane Major Business
    • 2.7.3 China Res Double-Crane Verapamil Hydrochloride Injection Product and Services
    • 2.7.4 China Res Double-Crane Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 China Res Double-Crane Recent Developments/Updates
  • 2.8 Shiyao YINHU Pharmaceutical
    • 2.8.1 Shiyao YINHU Pharmaceutical Details
    • 2.8.2 Shiyao YINHU Pharmaceutical Major Business
    • 2.8.3 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Product and Services
    • 2.8.4 Shiyao YINHU Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shiyao YINHU Pharmaceutical Recent Developments/Updates
  • 2.9 Jilin Jinsheng Pharmaceutical
    • 2.9.1 Jilin Jinsheng Pharmaceutical Details
    • 2.9.2 Jilin Jinsheng Pharmaceutical Major Business
    • 2.9.3 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Product and Services
    • 2.9.4 Jilin Jinsheng Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Jilin Jinsheng Pharmaceutical Recent Developments/Updates
  • 2.10 Shanghai Harvest Pharmaceutical
    • 2.10.1 Shanghai Harvest Pharmaceutical Details
    • 2.10.2 Shanghai Harvest Pharmaceutical Major Business
    • 2.10.3 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Product and Services
    • 2.10.4 Shanghai Harvest Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
  • 2.11 Jiangsu Langou Drug
    • 2.11.1 Jiangsu Langou Drug Details
    • 2.11.2 Jiangsu Langou Drug Major Business
    • 2.11.3 Jiangsu Langou Drug Verapamil Hydrochloride Injection Product and Services
    • 2.11.4 Jiangsu Langou Drug Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Jiangsu Langou Drug Recent Developments/Updates
  • 2.12 Jiangsu Ruinian Qianjin Pharmacy
    • 2.12.1 Jiangsu Ruinian Qianjin Pharmacy Details
    • 2.12.2 Jiangsu Ruinian Qianjin Pharmacy Major Business
    • 2.12.3 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Product and Services
    • 2.12.4 Jiangsu Ruinian Qianjin Pharmacy Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Jiangsu Ruinian Qianjin Pharmacy Recent Developments/Updates
  • 2.13 Chongqing Yaoyou Pharmacy
    • 2.13.1 Chongqing Yaoyou Pharmacy Details
    • 2.13.2 Chongqing Yaoyou Pharmacy Major Business
    • 2.13.3 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Product and Services
    • 2.13.4 Chongqing Yaoyou Pharmacy Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Chongqing Yaoyou Pharmacy Recent Developments/Updates
  • 2.14 Hubei Weishi
    • 2.14.1 Hubei Weishi Details
    • 2.14.2 Hubei Weishi Major Business
    • 2.14.3 Hubei Weishi Verapamil Hydrochloride Injection Product and Services
    • 2.14.4 Hubei Weishi Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Hubei Weishi Recent Developments/Updates
  • 2.15 Duoduo Pharmaceutical
    • 2.15.1 Duoduo Pharmaceutical Details
    • 2.15.2 Duoduo Pharmaceutical Major Business
    • 2.15.3 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Product and Services
    • 2.15.4 Duoduo Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Duoduo Pharmaceutical Recent Developments/Updates
  • 2.16 Harbin Pharm. Group Sanjing Pharmaceutical
    • 2.16.1 Harbin Pharm. Group Sanjing Pharmaceutical Details
    • 2.16.2 Harbin Pharm. Group Sanjing Pharmaceutical Major Business
    • 2.16.3 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Product and Services
    • 2.16.4 Harbin Pharm. Group Sanjing Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Harbin Pharm. Group Sanjing Pharmaceutical Recent Developments/Updates
  • 2.17 Chia Tai-Tianqing Pharmaceutical
    • 2.17.1 Chia Tai-Tianqing Pharmaceutical Details
    • 2.17.2 Chia Tai-Tianqing Pharmaceutical Major Business
    • 2.17.3 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Product and Services
    • 2.17.4 Chia Tai-Tianqing Pharmaceutical Verapamil Hydrochloride Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Verapamil Hydrochloride Injection by Manufacturer

  • 3.1 Global Verapamil Hydrochloride Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Verapamil Hydrochloride Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Verapamil Hydrochloride Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Verapamil Hydrochloride Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Verapamil Hydrochloride Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Verapamil Hydrochloride Injection Manufacturer Market Share in 2025
  • 3.5 Verapamil Hydrochloride Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Verapamil Hydrochloride Injection Market: Region Footprint
    • 3.5.2 Verapamil Hydrochloride Injection Market: Company Product Type Footprint
    • 3.5.3 Verapamil Hydrochloride Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Verapamil Hydrochloride Injection Market Size by Region
    • 4.1.1 Global Verapamil Hydrochloride Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Verapamil Hydrochloride Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Verapamil Hydrochloride Injection Average Price by Region (2021-2032)
  • 4.2 North America Verapamil Hydrochloride Injection Consumption Value (2021-2032)
  • 4.3 Europe Verapamil Hydrochloride Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Verapamil Hydrochloride Injection Consumption Value (2021-2032)
  • 4.5 South America Verapamil Hydrochloride Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Verapamil Hydrochloride Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Verapamil Hydrochloride Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Verapamil Hydrochloride Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Verapamil Hydrochloride Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Verapamil Hydrochloride Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Verapamil Hydrochloride Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Verapamil Hydrochloride Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Verapamil Hydrochloride Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Verapamil Hydrochloride Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Verapamil Hydrochloride Injection Market Size by Country
    • 7.3.1 North America Verapamil Hydrochloride Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Verapamil Hydrochloride Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Verapamil Hydrochloride Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Verapamil Hydrochloride Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Verapamil Hydrochloride Injection Market Size by Country
    • 8.3.1 Europe Verapamil Hydrochloride Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Verapamil Hydrochloride Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Verapamil Hydrochloride Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Verapamil Hydrochloride Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Verapamil Hydrochloride Injection Market Size by Region
    • 9.3.1 Asia-Pacific Verapamil Hydrochloride Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Verapamil Hydrochloride Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Verapamil Hydrochloride Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Verapamil Hydrochloride Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Verapamil Hydrochloride Injection Market Size by Country
    • 10.3.1 South America Verapamil Hydrochloride Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Verapamil Hydrochloride Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Verapamil Hydrochloride Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Verapamil Hydrochloride Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Verapamil Hydrochloride Injection Market Size by Country
    • 11.3.1 Middle East & Africa Verapamil Hydrochloride Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Verapamil Hydrochloride Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Verapamil Hydrochloride Injection Market Drivers
  • 12.2 Verapamil Hydrochloride Injection Market Restraints
  • 12.3 Verapamil Hydrochloride Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Verapamil Hydrochloride Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Verapamil Hydrochloride Injection
  • 13.3 Verapamil Hydrochloride Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Verapamil Hydrochloride Injection Typical Distributors
  • 14.3 Verapamil Hydrochloride Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Verapamil Hydrochloride Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Verapamil Hydrochloride Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Verapamil Hydrochloride Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Verapamil Hydrochloride Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Verapamil Hydrochloride Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Verapamil Hydrochloride Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Verapamil Hydrochloride Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Verapamil Hydrochloride Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Exela Pharma, Mankind Pharma, ACIC Pharmaceuticals, Zydus Pharmaceuticals, Gland Pharma, China Res Double-Crane, Shiyao YINHU Pharmaceutical, Jilin Jinsheng Pharmaceutical, Shanghai Harvest Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Verapamil Hydrochloride Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral
    Intravenous Injection
    Market segment by Application
    Hospital
    Clinics
    Other
    Major players covered
    Pfizer
    Exela Pharma
    Mankind Pharma
    ACIC Pharmaceuticals
    Zydus Pharmaceuticals
    Gland Pharma
    China Res Double-Crane
    Shiyao YINHU Pharmaceutical
    Jilin Jinsheng Pharmaceutical
    Shanghai Harvest Pharmaceutical
    Jiangsu Langou Drug
    Jiangsu Ruinian Qianjin Pharmacy
    Chongqing Yaoyou Pharmacy
    Hubei Weishi
    Duoduo Pharmaceutical
    Harbin Pharm. Group Sanjing Pharmaceutical
    Chia Tai-Tianqing Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Verapamil Hydrochloride Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Verapamil Hydrochloride Injection, with price, sales quantity, revenue, and global market share of Verapamil Hydrochloride Injection from 2021 to 2026.
    Chapter 3, the Verapamil Hydrochloride Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Verapamil Hydrochloride Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Verapamil Hydrochloride Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Verapamil Hydrochloride Injection.
    Chapter 14 and 15, to describe Verapamil Hydrochloride Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now